Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 11, Pages 2513-2522
Publisher
Wiley
Online
2013-07-14
DOI
10.1002/ijc.28384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification byKRASMutations in Advanced Colorectal Cancer
- (2013) Issa J. Dahabreh et al. ANNALS OF INTERNAL MEDICINE
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- (2013) Uri Ladabaum et al. ANNALS OF INTERNAL MEDICINE
- Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
- (2013) K. Ng et al. CLINICAL CANCER RESEARCH
- Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer
- (2013) A. Spreafico et al. CLINICAL CANCER RESEARCH
- Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells
- (2013) Erika Martinelli et al. INTERNATIONAL JOURNAL OF CANCER
- Risks of Colorectal and Other Cancers After Endometrial Cancer for Women With Lynch Syndrome
- (2013) Aung Ko Win et al. JNCI-Journal of the National Cancer Institute
- Adjuvant therapy in primary GIST: state-of-the-art
- (2012) P. Reichardt et al. ANNALS OF ONCOLOGY
- Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
- (2012) V. S. Warneke et al. ANNALS OF ONCOLOGY
- Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
- (2012) Alexander Stein et al. BMC CANCER
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Lynch syndrome diagnostics: decision-making process for germ-line testing
- (2012) Enrique Lastra et al. Clinical & Translational Oncology
- Molecular Tests for Colorectal Cancer Screening
- (2012) Linda J.W. Bosch et al. Clinical Colorectal Cancer
- Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
- (2012) A. Ballestrero et al. CURRENT CANCER DRUG TARGETS
- Targeted Therapy for Gastric Cancer
- (2012) Elizabeth C. Smyth et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- Bevacizumab in colorectal cancer: current and future directions
- (2012) Yvonne Yeung et al. Expert Review of Anticancer Therapy
- Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed
- (2012) James E. Allison et al. GASTROENTEROLOGY
- Identification of Lynch Syndrome Among Patients With Colorectal Cancer
- (2012) Leticia Moreira et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
- (2012) Hans-Joachim Schmoll et al. JOURNAL OF CLINICAL ONCOLOGY
- Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
- (2012) Sabine Tejpar et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
- (2012) A. D. Roth et al. JNCI-Journal of the National Cancer Institute
- A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin
- (2012) C. G. Fraser et al. JNCI-Journal of the National Cancer Institute
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- TFAP2E–DKK4and Chemoresistance in Colorectal Cancer
- (2012) Matthias P.A. Ebert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer
- (2012) Yifan Peng et al. WORLD JOURNAL OF SURGERY
- A future for faecal haemoglobin measurements in the medical laboratory
- (2012) C. G. Fraser ANNALS OF CLINICAL BIOCHEMISTRY
- PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- (2011) C. Mao et al. ANNALS OF ONCOLOGY
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer
- (2011) Fotios Loupakis et al. CANCER
- Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
- (2011) Toni M. Brand et al. CANCER BIOLOGY & THERAPY
- Colon Cancer Screening: Which Non-Invasive Filter Tests?
- (2011) Christian Pox DIGESTIVE DISEASES
- Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer
- (2011) Lucía Pérez-Carbonell et al. GUT
- Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany
- (2011) Arthi Vijayaraghavan et al. INTERNATIONAL JOURNAL OF CANCER
- Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue
- (2011) Richard D. Kennedy et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer
- (2011) Richard G. Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803
- (2011) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
- (2011) Scott M. Weissman et al. Journal of Genetic Counseling
- Fecal Occult Blood Testing When Colonoscopy Capacity is Limited
- (2011) Janneke A. Wilschut et al. JNCI-Journal of the National Cancer Institute
- C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
- (2011) Pragatheeshwar Thirunavukarasu et al. JNCI-Journal of the National Cancer Institute
- Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates
- (2011) Barry M. Berger et al. PATHOLOGY
- Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
- (2010) R. Labianca et al. ANNALS OF ONCOLOGY
- Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer
- (2010) Tomomi Yakabe et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases
- (2010) Robbert J. de Haas et al. ANNALS OF SURGICAL ONCOLOGY
- Intensive Risk-Adjusted Follow-up With the CEA, TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences
- (2010) Andrea Nicolini ARCHIVES OF SURGERY
- Cost-effectiveness of colorectal cancer screening – An overview
- (2010) Iris Lansdorp-Vogelaar et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors
- (2010) Jean-Yves Blay et al. CANCER
- All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer
- (2010) Helena Linardou et al. CANCER TREATMENT REVIEWS
- Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: A prospective validation study
- (2010) Helgi Birgisson et al. EUROPEAN JOURNAL OF CANCER
- Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
- (2010) Cecilia Guastadisegni et al. EUROPEAN JOURNAL OF CANCER
- Towards global consensus in the treatment of gastrointestinal stromal tumor
- (2010) Peter Reichardt et al. Expert Review of Anticancer Therapy
- One to 2-Year Surveillance Intervals Reduce Risk of Colorectal Cancer in Families With Lynch Syndrome
- (2010) Hans F.A. Vasen et al. GASTROENTEROLOGY
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours
- (2010) Marco Novelli et al. HISTOPATHOLOGY
- Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper
- (2010) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost-effectiveness analysis
- (2010) Leo G.M. van Rossum et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: Performances of immunochemical colorectal cancer screening
- (2010) Célia Berchi et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
- (2010) Axel Grothey JOURNAL OF CLINICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
- (2010) Alberto Bardelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
- (2010) Ramon Salazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis
- (2010) Ming Ming ZHU et al. Journal of Digestive Diseases
- The GIST paradigm: lessons for other kinase-driven cancers
- (2010) Cristina R Antonescu JOURNAL OF PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Mismatch repair deficient colorectal cancer in the era of personalized treatment
- (2010) Madeleine Hewish et al. Nature Reviews Clinical Oncology
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
- (2010) Josef Rüschoff et al. VIRCHOWS ARCHIV
- The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
- (2009) A. S. Strimpakos et al. ANNALS OF ONCOLOGY
- Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level
- (2009) In Ja Park et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
- (2009) Li-Chu Sun et al. BMC CANCER
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer
- (2009) Michael Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy Trial
- (2009) Vassiliki L. Tsikitis et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening
- (2009) Iris Lansdorp-Vogelaar et al. JNCI-Journal of the National Cancer Institute
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Serum tumour markers: how to order and interpret them
- (2009) C M Sturgeon et al. BMJ-British Medical Journal
- Surveillance after Curative Resection of Colorectal Cancer
- (2009) Adena Scheer et al. Clinics in Colon and Rectal Surgery
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update
- (2008) Paul Hewitson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version
- (2008) Toshirou Nishida et al. International Journal of Clinical Oncology
- Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer
- (2008) Isabelle Iwanicki-Caron et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence
- (2008) Grazia Grazzini et al. JOURNAL OF MEDICAL SCREENING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started